NovaXS Biotech
About this raise
NovaXS Biotech, with a valuation of $14 million, is raising funds on Republic. The company is developing needle-free self-injection technology for ease of use, painless drug delivery, and better care. NovaXS Biotech smart system aims to simplify the medication self-administration process and improve remote treatment outcomes with one simple click on the device. NovaXS Biotech has filed four patents to protect its technology, is finalizing prototypes, and targeting commercial launch in the second quarter of 2024. Alina Su, Jonathan Xing, and Alex You founded NovaXS Biotech in January 2021. The current crowdfunding campaign has a minimum target of $25,000 and a maximum target of $1.24 million. The campaign proceeds will be used to initiate licensing, launch the product, and promote sales.
Investment Overview
Invested : $114,193
Deal Terms
Total Commitments
- Platform
- Republic
- Start Date
- 12/06/2022
- Close Date
- 02/03/2023
$25,000
$1,235,000
$100
SAFE
Early Stage
RegCF
$14,000,000
20%
Company & Team
Company
- Year Founded
- 2021
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Distribution Model
- B2B
- Margin
- Medium
- Capital Intensity
- Low
Financials
-
Revenue
-
$137,000
as of FY2021
- Monthly Burn
-
$5,208
as of FY2021
-
Runway
-
24+ months
as of FY2021
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Ratings 
Company Funding & Growth
Funding history
- Total Prior Capital Raised
- $1,043,777
- VC Backed?
- Yes
| Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|
| 02/03/2023 | Republic | $14,000,000 | $114,193 | SAFE | Funded | RegCF |